GEODE CAPITAL MANAGEMENT, LLC
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,054,209
+$4,807,367 QoQ
Shares Held
996,235
+5.5% QoQ
Ownership
1.87%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. KALV ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in KALV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,054,209 | 996,235 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,246,842 | 944,077 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $11,311,212 | 928,671 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $10,640,401 | 941,212 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $10,561,880 | 915,241 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,965,321 | 822,352 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,622,794 | 830,984 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $9,497,871 | 806,271 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $7,731,391 | 651,888 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,718,088 | 630,048 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,025,810 | 521,891 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,323,825 | 480,425 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,674,424 | 467,484 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,690,987 | 398,075 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,019,604 | 414,859 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,906,627 | 397,015 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,029,043 | 409,026 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,000,543 | 377,970 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,424,043 | 368,140 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,081,156 | 337,277 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,407,489 | 327,267 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,280,706 | 225,419 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,617,171 | 207,877 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,399,248 | 198,285 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,466,267 | 191,669 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||